Skip to content
Est. 1998 proudly celebrating 27 years of standing behind American companies
Verified American Company Independently reviewed and approved · June 2026

ALCON INC (ALC)

$67.91 +1.04% NYSE: ALC · 15-min delayed
  • FORT WORTH, Texas
  • Public · NYSE: ALC
  • 25,942 employees
$32.6BMarket cap
$7.2BRevenue · FY2010
25,942Employees
ALCNYSE
2019IPO

About ALCON INC

Alcon is one of the leading visioncare companies in the world. Following nine years as a Novartis subsidiary, it was spun off as a public company in April 2019. Alcon operates in two segments: visioncare and surgical. Visioncare comprises contact lenses, lenscare solutions, and a suite of ocular health products. With brands like Dailies, Total1, and Air Optix, Alcon controls about one fourth of the US contact lens market. Surgical comprises intraocular lenses, ophthalmic surgical equipment, and consumables used during surgeries. Its main products include Centurion, a phacoemulsification device used during cataract surgeries, and a portfolio of IOLs including PanOptix and Vivity. Alcon has one of the largest installed bases of eye surgical equipment in the world.

This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.

American Credentials

Each credential is independently reviewed before it’s awarded · last reviewed Jun 9, 2026. How this is verified →

Reported figures

Financial summary

Revenue FY2010
$7.2B
Total assets
$10.1B
Market cap
$32.6B
Operating margin
-15.1%
Net margin
-11.4%

Source: SEC EDGAR · updated Jun 7, 2026

Multi-year

Revenue & profit trend

Revenue Net income
FY 2012

Financial statements

Income statement

Revenue
$228.4M
Operating expenses
$262.9M
Operating income
-$34.5M
Income tax
-$17.4M
Net income
-$26.1M
EPS (basic)
$-1.14
EPS (diluted)
$-1.14

Balance sheet

Total assets
$515.8M
Current assets
$31.4M
Total liabilities
$238.1M
Current liabilities
$154.3M
Shareholders’ equity
$277.6M

Cash flow

Operating cash flow
-$927.0K
Investing cash flow
-$79.0M
Financing cash flow
$87.4M
Net cash flow
$7.5M

Statements via Polygon.io (SEC filings)

NYSE: ALC
$67.91 +1.04%

15-minute delayed · data by Polygon.io

Past year · hover for prices

$62.02 $92.22

52-week range

Market cap
$32.6B
EPS (diluted)
$-1.14
Dividend yield
0.41%
Shares outstanding
479.8M
Open
Day range
Prev close
Volume
IPO date
Apr 9, 2019

Alcon Inc (ALC) Stock Price

  • Revenue declined 3% from FY2011 to FY2012.
  • Trading 26% below its 52-week high.
  • Pays a dividend yielding about 0.41% annually.

Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.

No reviews yet. Be the first to review ALCON INC.

Write a review
Newsroom

News about ALCON INC

News & sentiment via Polygon.io

FAQ

Alcon Inc: frequently asked questions

Is Alcon Inc an American company?

Yes — Alcon Inc is an American company headquartered in Fort Worth, Texas. Its American-origin credentials have been independently reviewed and verified by americancompanies.com.

Where is Alcon Inc headquartered?

Alcon Inc is headquartered in Fort Worth, Texas, United States.

Is Alcon Inc publicly traded?

Yes — Alcon Inc is a publicly traded company. Its stock trades under the ticker symbol ALC on the NYSE.

What does Alcon Inc do?

Alcon Inc is an American Medical Devices company in the Health & Beauty sector.

Explore

Similar companies

Browse all →